Sort
11,323 grants matching “glioblastoma”
Clinical development of cancer-specific MRS biomarkers in malignant gliomas
$329,925Changho Choi · Ut Southwestern Medical Center · R01 · FY2015 · CA
Mechanisms of acquired temozolomide resistance in glioblastoma multiforme
$329,925Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2017 · CA
Metabolic Regulators of Tumor Cell Growth
$329,925Ralph J Deberardinis · Ut Southwestern Medical Center · R01 · FY2015 · CA
Clinical development of cancer-specific MRS biomarkers in malignant gliomas
$329,925Changho Choi · Ut Southwestern Medical Center · R01 · FY2014 · CA
Mechanisms of acquired temozolomide resistance in glioblastoma multiforme
$329,925Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2013 · CA
The role of a histone H4 phosphorylation in drug resistance
$329,925Zhiguo Zhang · Mayo Clinic Rochester · R01 · FY2012 · CA
Clinical development of cancer-specific MRS biomarkers in malignant gliomas
$329,925Changho Choi · Ut Southwestern Medical Center · R01 · FY2016 · CA
Molecular mechanisms of GBM radioresistance and strategies for radiosensitization
$329,925Sandeep Burma · Ut Southwestern Medical Center · R01 · FY2015 · CA
Mechanisms of acquired temozolomide resistance in glioblastoma multiforme
$329,925Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2016 · CA
Defining the metabolic phenotype of low grade gliomas in vivo
$329,925Elizabeth A Maher · Ut Southwestern Medical Center · R01 · FY2015 · CA
Clinical development of cancer-specific MRS biomarkers in malignant gliomas
$329,925Changho Choi · Ut Southwestern Medical Center · R01 · FY2017 · CA
Mechanisms of acquired temozolomide resistance in glioblastoma multiforme
$329,925Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2015 · CA
The role of a histone H4 phosphorylation in drug resistance
$329,925Zhiguo Zhang · Mayo Clinic Rochester · R01 · FY2015 · CA
Non-canonical signal pathway for Crk in breast cancer
$329,925Raymond B Birge · Rbhs-New Jersey Medical School · R01 · FY2015 · CA
Defining the metabolic phenotype of low grade gliomas in vivo
$329,925Elizabeth A Maher · Ut Southwestern Medical Center · R01 · FY2016 · CA
Genetic Dissection of Glioblastoma: Cell of Origin
$329,873Robert M Bachoo · Ut Southwestern Medical Center · R01 · FY2013 · NS
Targeting the Novel PI5P4K Pathway to Induce Glioblastoma Senescence
$329,809Atsuo Sasaki · University Of Cincinnati · R01 · FY2015 · NS
Pro-Drug Enolase Inhibitors in Precision Oncology
$329,668Steven W Millward · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Pro-Drug Enolase Inhibitors in Precision Oncology
$329,668Steven W Millward · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Metabolic Regulators of Tumor Cell Growth
$329,579Ralph J Deberardinis · Ut Southwestern Medical Center · R01 · FY2012 · CA
Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme
$329,567Scott Michael Welford · University Of Miami School Of Medicine · R01 · FY2019 · CA
Defining the metabolic phenotype of low grade gliomas in vivo
$329,493Elizabeth A Maher · Ut Southwestern Medical Center · R01 · FY2012 · CA
Project 2: Clinical evaluation of a novel oHSV in recurrent human GBM
$329,476E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2019 · CA
Role of KLF6 Tumor Suppressor in Hepatocellular Cancer
$329,471Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · DK
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma
$329,461Alfredo Quinones-Hinojosa · Johns Hopkins University · R01 · FY2015 · CA